RU2002107675A - Лекарственные средства с содержанием ксеногенных олиго- или/и полирибонуклеотидов - Google Patents
Лекарственные средства с содержанием ксеногенных олиго- или/и полирибонуклеотидовInfo
- Publication number
- RU2002107675A RU2002107675A RU2002107675/15A RU2002107675A RU2002107675A RU 2002107675 A RU2002107675 A RU 2002107675A RU 2002107675/15 A RU2002107675/15 A RU 2002107675/15A RU 2002107675 A RU2002107675 A RU 2002107675A RU 2002107675 A RU2002107675 A RU 2002107675A
- Authority
- RU
- Russia
- Prior art keywords
- polyribonucleotides
- oligo
- treatment
- use according
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Claims (5)
1. Применение ксеногенных олиго- или/и полирибонуклеотидов для приготовления безводного лекарственного средства для наружного лечения инфекций вирусного герпеса или/и кожных опухолей, причем лекарственное средство применяется при рецидиве один раз.
2. Применение по п.1, отличающееся тем, что лекарственное средство содержит дополнительно физиологически совместимые наполнители, вспомогательные вещества, разбавители или/и добавки.
3. Применение по п.1 или 2, отличающееся тем, что ксеногенные олиго- или/и полирибонуклеотиды происходят из организмов, которые по своей истории развития далеко отстоят от подлежащего лечению организма.
4. Применение по любому из предшествующих пунктов при лечении кожи или/и слизистой оболочки, пораженных вирусом пузырькового герпеса или/и вирусом ветряной оспы зостер.
5. Способ лечения инфекций герпесного вируса или/и кожных опухолей, отличающийся тем, что пациенту, нуждающемуся в таком лечении, или животному вводятся ксеногенные олиго- или/и полирибонуклеотиды в виде безводной композиции в эффективном количестве 0,1 мг и более на дозированную единицу один раз при рецидиве.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19940748A DE19940748A1 (de) | 1999-08-27 | 1999-08-27 | Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide |
DE19940748.7 | 1999-08-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2002107675A true RU2002107675A (ru) | 2004-01-10 |
RU2270669C2 RU2270669C2 (ru) | 2006-02-27 |
Family
ID=7919851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002107675/15A RU2270669C2 (ru) | 1999-08-27 | 2000-08-24 | Лекарственные средства с содержанием ксеногенных олиго- или/и полирибонуклеотидов |
Country Status (23)
Country | Link |
---|---|
US (1) | US20060069057A1 (ru) |
EP (1) | EP1206267B1 (ru) |
JP (1) | JP2003508442A (ru) |
KR (1) | KR100840804B1 (ru) |
CN (1) | CN1177591C (ru) |
AT (1) | ATE277622T1 (ru) |
AU (1) | AU774877B2 (ru) |
BR (1) | BR0013645A (ru) |
CA (1) | CA2382034A1 (ru) |
CZ (1) | CZ2002702A3 (ru) |
DE (2) | DE19940748A1 (ru) |
ES (1) | ES2230181T3 (ru) |
HK (1) | HK1048263A1 (ru) |
HU (1) | HUP0202888A3 (ru) |
IL (1) | IL148336A (ru) |
MX (1) | MXPA02001995A (ru) |
NO (1) | NO20020937D0 (ru) |
NZ (1) | NZ516943A (ru) |
PL (1) | PL197393B1 (ru) |
PT (1) | PT1206267E (ru) |
RU (1) | RU2270669C2 (ru) |
WO (1) | WO2001015704A1 (ru) |
ZA (1) | ZA200201301B (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10131148A1 (de) * | 2001-06-28 | 2003-01-16 | I P L Internat Pharmaceutics L | Xenogene Oligo- oder/und Polyribonukleotide als Mittel zur Behandlung von malignen Tumoren |
US20120071543A1 (en) * | 2010-05-14 | 2012-03-22 | Carter Jacob L | Formulations of diluted genetic material and methods for making same |
US9603898B2 (en) | 2011-03-23 | 2017-03-28 | Deseret Biologicals, Inc. | Formulations of diluted amino acid segments and methods for making same |
RU2620069C2 (ru) * | 2014-06-26 | 2017-05-22 | Аоварт Гмбх | Вещество и способ модуляции пролиферации и дифференцировки регуляторных, стволовых и других соматических клеток |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2547696A1 (de) * | 1975-10-24 | 1977-04-28 | Beecham Group Ltd | Antivirale substanz, verfahren zu ihrer herstellung und diese substanz enthaltende arzneipraeparate |
SE7607496L (sv) * | 1976-07-01 | 1978-01-02 | Astra Laekemedel Ab | Sett for bekempning av virusinfektioner |
DE2824411A1 (de) * | 1978-06-03 | 1979-12-13 | Boehringer Sohn Ingelheim | Antiviral wirksame t-rna-praeparate |
US4924624A (en) * | 1987-10-22 | 1990-05-15 | Temple University-Of The Commonwealth System Of Higher Education | 2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof |
US5512668A (en) * | 1991-03-06 | 1996-04-30 | Polish Academy Of Sciences | Solid phase oligonucleotide synthesis using phospholane intermediates |
FR2713487B1 (fr) * | 1993-12-09 | 1996-02-02 | Labo Life | Solutions de type homéopathique contenant un acide nucléique utilisables notamment dans la prévention ou le traitement de maladies infectieuses ou de maladies impliquant le dysfonctionnement d'un gène. |
DE4438918A1 (de) * | 1994-11-04 | 1996-05-09 | Hoechst Ag | Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung |
US6353055B1 (en) * | 1994-11-18 | 2002-03-05 | Supratek Pharma Inc. | Polynucleotide compositions |
US5834443A (en) * | 1996-05-21 | 1998-11-10 | Masiello; Domenick J. | Composition and method for treating herpes simplex |
-
1999
- 1999-08-27 DE DE19940748A patent/DE19940748A1/de not_active Withdrawn
-
2000
- 2000-08-24 HU HU0202888A patent/HUP0202888A3/hu unknown
- 2000-08-24 CZ CZ2002702A patent/CZ2002702A3/cs unknown
- 2000-08-24 AU AU28081/01A patent/AU774877B2/en not_active Ceased
- 2000-08-24 PT PT00991044T patent/PT1206267E/pt unknown
- 2000-08-24 BR BR0013645-0A patent/BR0013645A/pt not_active Application Discontinuation
- 2000-08-24 NZ NZ516943A patent/NZ516943A/en unknown
- 2000-08-24 CN CNB008121222A patent/CN1177591C/zh not_active Expired - Fee Related
- 2000-08-24 WO PCT/EP2000/008279 patent/WO2001015704A1/de active IP Right Grant
- 2000-08-24 RU RU2002107675/15A patent/RU2270669C2/ru not_active IP Right Cessation
- 2000-08-24 DE DE50008024T patent/DE50008024D1/de not_active Expired - Fee Related
- 2000-08-24 EP EP00991044A patent/EP1206267B1/de not_active Expired - Lifetime
- 2000-08-24 CA CA002382034A patent/CA2382034A1/en not_active Abandoned
- 2000-08-24 KR KR1020027002430A patent/KR100840804B1/ko not_active IP Right Cessation
- 2000-08-24 JP JP2001519918A patent/JP2003508442A/ja active Pending
- 2000-08-24 MX MXPA02001995A patent/MXPA02001995A/es active IP Right Grant
- 2000-08-24 ES ES00991044T patent/ES2230181T3/es not_active Expired - Lifetime
- 2000-08-24 PL PL353881A patent/PL197393B1/pl unknown
- 2000-08-24 IL IL14833600A patent/IL148336A/xx not_active IP Right Cessation
- 2000-08-24 AT AT00991044T patent/ATE277622T1/de not_active IP Right Cessation
-
2002
- 2002-02-15 ZA ZA200201301A patent/ZA200201301B/en unknown
- 2002-02-26 NO NO20020937A patent/NO20020937D0/no not_active Application Discontinuation
-
2003
- 2003-01-23 HK HK03100562A patent/HK1048263A1/xx not_active IP Right Cessation
-
2005
- 2005-10-13 US US11/250,067 patent/US20060069057A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20020937L (no) | 2002-02-26 |
WO2001015704A1 (de) | 2001-03-08 |
KR100840804B1 (ko) | 2008-06-23 |
HUP0202888A2 (hu) | 2002-12-28 |
AU774877B2 (en) | 2004-07-08 |
ZA200201301B (en) | 2002-11-27 |
CA2382034A1 (en) | 2001-03-08 |
CN1177591C (zh) | 2004-12-01 |
PT1206267E (pt) | 2005-01-31 |
AU2808101A (en) | 2001-03-26 |
PL353881A1 (en) | 2003-12-01 |
NZ516943A (en) | 2003-09-26 |
EP1206267A1 (de) | 2002-05-22 |
CN1371282A (zh) | 2002-09-25 |
NO20020937D0 (no) | 2002-02-26 |
DE50008024D1 (de) | 2004-11-04 |
US20060069057A1 (en) | 2006-03-30 |
ATE277622T1 (de) | 2004-10-15 |
JP2003508442A (ja) | 2003-03-04 |
IL148336A0 (en) | 2002-09-12 |
IL148336A (en) | 2005-11-20 |
ES2230181T3 (es) | 2005-05-01 |
DE19940748A1 (de) | 2001-03-01 |
CZ2002702A3 (cs) | 2002-07-17 |
PL197393B1 (pl) | 2008-03-31 |
HK1048263A1 (en) | 2003-03-28 |
BR0013645A (pt) | 2002-05-07 |
EP1206267B1 (de) | 2004-09-29 |
MXPA02001995A (es) | 2002-09-25 |
KR20020031596A (ko) | 2002-05-02 |
RU2270669C2 (ru) | 2006-02-27 |
HUP0202888A3 (en) | 2005-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0314236A (pt) | Formulação de oligonucleotìdeo, composição farmacêutica, kit, composto antiviral, preparação de oligonucleotìdeo e métodos para seleção de um oligonucleotìdeo antiviral para uso como um agente antiviral, para profilaxia ou tratamento de uma infecção viral em um paciente, para tratamento profilático de câncer causado por oncovìrus, para identificação de um composto que altera a ligação de um oligonucleotìdeo a pelo menos um componente viral, para purificação da ligação de oligonucleotìdeos a pelo menos um componente viral e para enriquecimento de oligonucleotìdeos a partir de um agrupamento de oligonucleotìdeos | |
RU94002475A (ru) | Фармацевтическая композиция и ее применение для лечения вирусных инфекций | |
BR0210838A (pt) | Composto, formulação farmacêutica, uso de um composto, métodos de prevenção e/ou tratamento de condições associadas com glicogênio sintase quinase-3, e de doenças, e medicação contraceptiva, e, processos para a preparação de um composto | |
RU97115713A (ru) | Соединения, содержащие бензопиран и способ их применения | |
RU95106821A (ru) | Циклопептиды, способ их получения, фармацевтическая композиция и способ ее получения | |
BR9811055A (pt) | Composto , uso do mesmo, composição farmacêutica, e, processo para tratamento de doença ou condição médica mediada pelo fator xa | |
JP2001510795A5 (ru) | ||
EP3305305B1 (en) | Silicate containing compositions and methods of treatment | |
RU95101385A (ru) | Продукты, содержащие g-csf и tnf связующие протеина | |
DE58901002D1 (de) | Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken. | |
WO1991002529A2 (en) | Product and method for killing abnormal vertebrate cells | |
RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
RU2008126108A (ru) | Фармацевтическая композиция для лечения остеоартрита, содержащая клодроновую кислоту и гиалуроновую кислоту | |
NZ324380A (en) | Therapeutic benzimidazole compounds and their use in treatment of virus infections | |
RU2002107675A (ru) | Лекарственные средства с содержанием ксеногенных олиго- или/и полирибонуклеотидов | |
ES2148234T3 (es) | Composicion farmaceutica a base de flavopereirina y su utilizacion en el tratamiento del virus vih. | |
DE69929616D1 (de) | Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen | |
ETTELDORF et al. | TREATMENT OF ASCARIASIS IN CHILDREN: Use of 1-Diethylacarbamyl-4-Methyl Piperazine Dihydrogen | |
KR890014124A (ko) | Il-6 분자의 사용방법 | |
RU2107502C1 (ru) | Ветеринарный препарат, обладающий широким спектром действия, - йод однохлористый | |
RU2196576C1 (ru) | Способ лечения больных геморрагической лихорадкой с почечным синдромом (глпс) | |
EP1203585B1 (en) | Anti-ischemic agent | |
RO113302B1 (ro) | Medicament normolipemiant si antineoplazic | |
ES2031930T3 (es) | Un metodo para obtener una preparacion liofilizada que contiene aspoxicilina como ingrediente activo. | |
RU94045140A (ru) | Фармацевтическая композиция для профилактики или лечения вирусных заболеваний, способ ее получения и применение антагониста брадикинина или его физиологически переносимой соли в качестве средства для профилактики или лечения вирусных заболеваний |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20090825 |